Durable Complete Responses in Some Recurrent High Grade Glioma Patients Treated with Toca 511 & Toca FC.

about

A Critical Overview of Targeted Therapies for Glioblastoma

P2860

Q58122179-66EB1B55-A98C-462E-BC34-DA3504C16445

P2860

Durable Complete Responses in Some Recurrent High Grade Glioma Patients Treated with Toca 511 & Toca FC.

Item

http://www.wikidata.org/entity/Q55457095

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Durable Complete Responses in ...... eated with Toca 511 & Toca FC.

@en

Durable Complete Responses in ...... eated with Toca 511 & Toca FC.

@nl

type

Item

label

Durable Complete Responses in ...... eated with Toca 511 & Toca FC.

@en

Durable Complete Responses in ...... eated with Toca 511 & Toca FC.

@nl

prefLabel

Durable Complete Responses in ...... eated with Toca 511 & Toca FC.

@en

Durable Complete Responses in ...... eated with Toca 511 & Toca FC.

@nl

P1476

Durable Complete Responses in ...... eated with Toca 511 & Toca FC.

@en

P2093

Albert Lai

http://www.w3.org/2001/XMLSchema#string

Asha Das

http://www.w3.org/2001/XMLSchema#string

Bob Carter

http://www.w3.org/2001/XMLSchema#string

Clark C Chen

http://www.w3.org/2001/XMLSchema#string

Daniel J Hogan

http://www.w3.org/2001/XMLSchema#string

David Piccioni

http://www.w3.org/2001/XMLSchema#string

Dawn Gammon

http://www.w3.org/2001/XMLSchema#string

Derek Ostertag

http://www.w3.org/2001/XMLSchema#string

Douglas J Jolly

http://www.w3.org/2001/XMLSchema#string

Harry E Gruber

http://www.w3.org/2001/XMLSchema#string

P2860

TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions

Years of life lost (YLL) from cancer is an important measure of population burden--and should be considered when allocating research funds

Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Differential analysis of gene regulation at transcript resolution with RNA-seq

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813.

Pathways of fluid drainage from the brain--morphological aspects and immunological significance in rat and man.

Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial.

Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials.

P31

scholarly article

P356

10.1093/NEUONC/NOY075

http://www.w3.org/2001/XMLSchema#string

P50

Phioanh Nghiemphu

P577

2018-05-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29762717

http://www.w3.org/2001/XMLSchema#string

P932

6120351

http://www.w3.org/2001/XMLSchema#string

Durable Complete Responses in Some Recurrent High Grade Glioma Patients Treated with Toca 511 & Toca FC.

about

P2860

P2860

Durable Complete Responses in Some Recurrent High Grade Glioma Patients Treated with Toca 511 & Toca FC.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P50

P577

P698

P932